Cubist Pharmaceuticals Inc $61.50

up +0.10


29/7/2014 11:04 AM  |  NASDAQ : CBST  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get CBST Trend Analysis - it has underperformed the S&P 500 by 7%

Partner Headlines

  1. Morning Market Losers

    Benzinga
  2. Jefferies Raises Price Target On Cubist Pharmaceuticals

    Benzinga
  3. Benzinga's Top #PreMarket Gainers

    Benzinga
  4. Cubist Readies For Takeoff With New Antibiotic Launch

    IBD
  5. Cubist Pharma Reports Publicant of Pivotal Data from SIVEXTRO ESTABLISH-2 ...

    Benzinga
  6. Morning Market Movers

    Benzinga
  7. Benzinga's Top #PreMarket Gainers

    Benzinga
  8. Forest Laboratories Is an Option for Wealthy Investors Who Could Afford ...

    GuruFocus
  9. Credit Suisse Maintains on Cubist Pharmaceuticals

    Benzinga
  10. Cubist Submits CTA to Dutch Competent Authority and Ethics Committee to ...

    Benzinga
  11. Cubist Announces FDA Acceptance of Tedizolid New Drug Application with ...

    Benzinga
  12. Cubist Announces FDA Accepts Tedizolid NDA with Priority Review

    Benzinga
  13. Cubist drug passes 2nd test

    IBD
  14. Cubist Antibiotic Passes Second Test; FDA Filing Next

    IBD
  15. Stock Futures Sharply Higher; AerCap Surges On Acquisition

    IBD
  16. Cubist antibiotic passes test

    IBD
  17. Cubist Antibiotic Shines In Trials; Stock Jumps

    IBD
  18. Michael Price's Top Sells - 11 Gurus Exit SFD

    GuruFocus
  19. Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  20. UPDATE: Wedbush Downgrades Cubist Pharmaceuticals Following Slight Q3:13 ...

    Benzinga
  21. Stocks Open Down In Firm Trade; Cree Crumbles On Q3 Results

    IBD
  22. Cubist Pharma Announces Submission of NDA for Tedizolid for Treatment of ...

    Benzinga
  23. Cubist Announces FDA Approval for Expanded Use of ENTEREG

    Benzinga
  24. UPDATE: Oppenheimer Initiates Coverage on Cubist Pharmaceuticals on Strong ...

    Benzinga
  25. UPDATE: Mizuho Securities Upgrades Cubist Pharmaceuticals on Pending Acquisitions ...

    Benzinga
  26. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  27. UPDATE: Leerink Swann Upgrades Cubist Pharmaceuticals Following Acquisition ...

    Benzinga
  28. Benzinga's Top Upgrades

    Benzinga
  29. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  30. HSR Waiting Period Expires for Cubist, Optimer Deal

    Benzinga
  31. Cubist Pharmaceuticals Issues $800M of Convertible Senior Notes

    Benzinga
  32. Cubist Pharma Reports Pricing of $700M in Convertible Senior Notes, Expecting ...

    Benzinga
  33. UPDATE: Aegis Capital Upgrades Cubist Pharmaceuticals Following Trius/Optimer ...

    Benzinga
  34. Benzinga's Top Upgrades

    Benzinga
  35. Mid-Afternoon Market Update: Fed Leaves Rates Unchanged; Green Dot Rises

    Benzinga
  36. UPDATE: Cantor Fitzgerald Raises PT on Cubist Pharmaceuticals

    Benzinga
  37. Mid-Day Market Update: Questcor Shares Jump On Upbeat Earnings, Riverbed ...

    Benzinga
  38. Mid-Morning Market Update: Markets Open Higher, MasterCard Profit Tops ...

    Benzinga
  39. UPDATE: Goldman Sachs Downgrades Cubist Pharmaceuticals Following Removal ...

    Benzinga
  40. Benzinga's Top Pre-Market Losers

    Benzinga
  41. Benzinga's Top Pre-Market Gainers

    Benzinga
  42. Benzinga's Top Upgrades

    Benzinga
  43. Benzinga Market Primer: Wednesday, July 31: Futures Higher Heading Into ...

    Benzinga
  44. Cubist Announces Acquisitions of Trius Therapeutics and Optimer Pharmaceuticals ...

    Benzinga
  45. Benzinga's M&A Chatter for Tuesday July 30, 2013

    Benzinga
  46. Cubist Pharmaceuticals to Acquire Optimer Pharmaceuticals For $10.75 In ...

    Benzinga
  47. Cubist Pharmaceuticals to Acquire Trius Therapeutics for $13.50 per Share; ...

    Benzinga
  48. Cubist Pharmaceuticals to Acquire Trius Therapeutics For $13.50 Per Share

    Benzinga
  49. Magic Formula Formulator Joel Greenblatt's Top 5 New Stock Picks

    GuruFocus
  50. UPDATE: Aegis Capital Initiates Coverage on Cubist Pharmaceuticals with ...

    Benzinga
Trading Center